Impact of #COVID19 in cancer patients: China data in JAMA https://t.co/5UiLQLGQUO showed 5.6% overall case fatality rate. The Lancet paper https://t.co/QAEzI0S1Rt revealed 40% severe event rate (mechanical ventilation or death). And increased to 75% with recent chemo or surgery.
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2020 – Apr 2021Where it's discussed
-
News58 articles
-
X / Twitter10 posts
-
Blogs9 articles
-
Facebook8 posts
-
YouTube2 videos
AI synopsis
What people are saying
Discussions show strong agreement with the article’s findings, citing statistics like a 5.6% case fatality rate and a 40% severe event rate, with some emphasizing the importance of intensified care for cancer patients, which demonstrates high interest and engagement. The tone varies from clinically focused to slightly speculative about treatment adjustments, highlighting the potential impact on healthcare approaches.
Most discussions acknowledge the findings that cancer patients face higher risks and worse outcomes with COVID-19, indicating general consensus on the study's conclusions.
The posts demonstrate high interest by referencing detailed statistics and implications, such as the fatality rate and severe event rate, showing engagement with the study’s data.
Several comments delve into the clinical implications and methodological details, reflecting deep engagement, e.g., discussing the need for cautious management and referencing supplementary tables.
The discussions imply that these findings could influence clinical practices and health policies, highlighting the importance of monitoring cancer patients more carefully during the pandemic.
Abstract in brief
- This study examines how COVID-19 affects cancer patients in China, focusing on the severity and outcomes of the infection in this vulnerable group.
- It finds that cancer patients with COVID-19 tend to have worse health outcomes, including higher rates of severe illness and mortality, compared to those without cancer.
- The research emphasizes the importance of carefully managing and monitoring cancer patients during the pandemic to reduce their risk of severe COVID-19 complications.
Top posts
Most liked on X and Bluesky@AlexJohnLondon @IanJPereira Yes, but the table is in the Supplement here https://t.co/nTIBF4sN6L
En este trabajo se demostró que los pacientes con cáncer tuvieron peor evolución producto de la infección por #COVID_19 por lo que recomiendan a los médicos que atienden a estos pacientes cuidados más intensivos en caso de deterioro rápido https://t.co/3l2wCyqEnh https://t.co/Cncdeexe9v
RT @jcragostini: En este trabajo se demostró que los pacientes con cáncer tuvieron peor evolución producto de la infección por #COVID_19 po…
RT @anup_kasi: Impact of #COVID19 in cancer patients: China data in JAMA https://t.co/5UiLQLGQUO showed 5.6% overall case fatality rate. Th…
“Patients with cancer might have a higher risk of #COVID19 than individuals without cancer”, says a study in @TheLancet #HealthCareServices #Cancer Read more in the research paper
All mentions
COVID Vaccine and Cancer: Guidelines and Considerations
Full live video coming soon discussing the topic but since its such a big topic to cover I wanted to put out something quick and to the point to let everyone know that if you have cancer or previously had cancer medical…
Risk Groups for COVID-19 in Cancer Patients
This video examines how COVID-19 affects cancer patients, highlighting their increased risk of severe illness and mortality. The importance of careful management and monitoring of this vulnerable group during the…
“Patients with cancer might have a higher risk of #COVID19 than individuals without cancer”, says a study in @TheLancet #HealthCareServices #Cancer Read more in the research paper
@RandySweisMD @agrothey A lot of
The Lancet oncólogo #Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China https://t.co/uG7XZMbrw3 ¿Que se espera en estos pacientes? ¿Será que la cirugía oncológica tendría que esperar? ⤵️ https://t.co/0rwtTg34G7
RT @anup_kasi: Impact of #COVID19 in cancer patients: China data in JAMA https://t.co/5UiLQLGQUO showed 5.6% overall case fatality rate. Th…
RT @jcragostini: En este trabajo se demostró que los pacientes con cáncer tuvieron peor evolución producto de la infección por #COVID_19 po…
RT @jcragostini: En este trabajo se demostró que los pacientes con cáncer tuvieron peor evolución producto de la infección por #COVID_19 po…
RT @anup_kasi: Impact of #COVID19 in cancer patients: China data in JAMA https://t.co/5UiLQLGQUO showed 5.6% overall case fatality rate. Th…
En este trabajo se demostró que los pacientes con cáncer tuvieron peor evolución producto de la infección por #COVID_19 por lo que recomiendan a los médicos que atienden a estos pacientes cuidados más intensivos en caso de deterioro rápido https://t.co/3l2wCyqEnh https://t.co/Cncdeexe9v
Impact of #COVID19 in cancer patients: China data in JAMA https://t.co/5UiLQLGQUO showed 5.6% overall case fatality rate. The Lancet paper https://t.co/QAEzI0S1Rt revealed 40% severe event rate (mechanical ventilation or death). And increased to 75% with recent chemo or surgery.
@AlexJohnLondon @IanJPereira Yes, but the table is in the Supplement here https://t.co/nTIBF4sN6L